The results showed that although the ITE+PD1 group had a trend of slower tumor growth compared to the DMSO control group ( Figure 1 F,G), the growth curve difference did not reach statistical significance ( p > 0.05).
← all excerpts
AHR Agonist ITE Boosted PD1 Antibody's Effects by Inhibiting Myeloid-Derived Cells Suppressive Cells in an Orthotopic Mouse Glioma Model.
2
0.0500
0.0500
The sentences
ITE showed a trend of M-MDSC reduction, yet not reaching statistical significance.